S-ECD/RBD monolonal antibody (1) | HMB001-N

S-ECD/RBD monolonal antibody (1) | HMB001-N | Gentaur UK, US & Europe Distribution

Host: Human

Reactivity: COVID-19

Application: ELISA: 1:320000 WB: 1:1000~2000 Neutralization

Background: Fully humanized monoclonal antibody paired with human monoclonal antibody LOCUS:QHD43416 1273aa linear VRL 18-MAR-2020 DEFINITION: S-ECD/RBD protein [Severe acute respiratory syndrome coronavirus 2] ACCESSION:QHD43416 VERSION:QHD43416.1 DBSOURCE:accession MN908947.3 SOURCE:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) ORGANISM:Viruses; Riboviria; Nidovirales; Cornidovirineae; Coronaviridae;Orthocoronavirinae; Betacoronavirus; Sarbecovirus.

Concentration: 2mg/ml in PBS, pH7.2

Purification: The antibody was purified from 293f recombinant protein and the purity is > 95% (by SDS-PAGE) .

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: S-ECD/RBD mAb detects endogenous levels of S-ECD/RBD protein.

Note: For research use only, not for use in diagnostic procedure.

Alternative Name: surface glycoprotein; S-ECD/RBD; Severe acute respiratory syndrome coronavirus 2; SARS-CoV-2; HCoV-19; SARS2; 2019-nCoV; COVID-19; COVID-19 virus; Human coronavirus 2019

Immunogen: Fully humanized monoclonal antibody paired with human monoclonal antibody, corresponding to COV-19 S-ECD/RBD.